SCHEMBL709944

SCHEMBL709944

O[Si](O)(c1ccccc1)c1ccccc1.[LiH].[LiH]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
CA4 P22748 2/20 0.37
CA14 Q9ULX7 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
GLA P06280 1/20 0.37
CA3 P07451 1/20 0.37
CA9 Q16790 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
BBOX1 O75936 2/20 0.35
EHMT2 Q96KQ7 1/20 0.35
EHMT1 Q9H9B1 1/20 0.35
APP P05067 1/20 0.35
ALDH1A1 P00352 3/20 0.33
IDO1 P14902 2/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9345851 1.00 ESR1 (0.40) ESR1ESR2CA4CA14CA12
SCHEMBL49494 0.97 ESR1 (0.42) ESR1ESR2CA4CA14CA12
SCHEMBL27700114 0.93 ESR1 (0.40) ESR1ESR2CA4CA14CA12
SCHEMBL28443818 0.93 ESR1 (0.40) ESR1ESR2CA4CA14CA12
SCHEMBL28289364 0.93 ESR1 (0.40) ESR1ESR2CA4CA14CA12
Hydrochloric Acid SCHEMBL28156324 0.93 ESR1 (0.40) ESR1ESR2CA4CA14CA12
SCHEMBL11904130 0.90 ESR1 (0.39) ESR1ESR2CA4CA14CA12
SCHEMBL4276199 0.88 ESR1 (0.48) ESR1ESR2CA4CA14CA12
Formaldehyde SCHEMBL8724973 0.88 ESR1 (0.37) ESR1ESR2CA4CA14CA12
SCHEMBL4619383 0.88 ESR1 (0.37) ESR1ESR2CA4CA14CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820733-B2 Process for producing sulfonic acid group-containing monomer ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-21 US claimed
EP-3766866-B1 METHOD FOR PRODUCING SULFONIC-ACID-GROUP-CONTAINING MONOMER ASAHI CHEMICAL IND (JP) 2023-10-25 EP claimed
EP-3766866-A1 METHOD FOR PRODUCING SULFONIC-ACID-GROUP-CONTAINING MONOMER Asahi Kasei Kabushiki Kaisha (JP) 2021-01-20 EP claimed
US-20200399210-A1 PROCESS FOR PRODUCING SULFONIC ACID GROUP-CONTAINING MONOMER ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-12-24 US claimed
CN-111511716-A Method for producing sulfonic acid group-containing monomer 旭化成株式会社 2020-08-07 CN claimed
WO-2019176425-A1 METHOD FOR PRODUCING SULFONIC-ACID-GROUP-CONTAINING MONOMER 旭化成株式会社 2019-09-19 WO claimed
US-20030042462-A1 Magnetic fluids RIFFLE JUDY S (US) 2003-03-06 US claimed
US-6464968-B2 BLOCK COPOLYMER STABILIZER, MAGNETIC PARTICLES AND A FLUID POLYSILOXANE MEDIUM, THE STABILIZER CONTAINS A BLOCK CAPABLE OF CHELATING THE METAL PARTICLES, AND END BLOCK IS COMPATIBLE WITH THE POLYSILOXANE MEDIUM; TREATING RETINAL DETACHMENT VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2002-10-15 US claimed
US-20020141942-A1 MAGNETIC FLUIDS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2002-10-03 US claimed
US-11820733-B2 Process for producing sulfonic acid group-containing monomer ASAHI KASEI KABUSHIKI KAISHA (JP) 2023-11-21 US disclosed
EP-3766866-B1 METHOD FOR PRODUCING SULFONIC-ACID-GROUP-CONTAINING MONOMER ASAHI CHEMICAL IND (JP) 2023-10-25 EP disclosed
CN-111511716-B Method for producing sulfonic acid group-containing monomer 旭化成株式会社(JP) 2023-01-13 CN disclosed
EP-3766866-A1 METHOD FOR PRODUCING SULFONIC-ACID-GROUP-CONTAINING MONOMER Asahi Kasei Kabushiki Kaisha (JP) 2021-01-20 EP disclosed
US-20200399210-A1 PROCESS FOR PRODUCING SULFONIC ACID GROUP-CONTAINING MONOMER ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-12-24 US disclosed
US-20030113606-A1 Biocompatible membranes of block copolymers and fuel cells produced therewith POWERZYME, INC. 2003-06-19 US disclosed
US-20030049511-A1 Stabilized biocompatible membranes of block copolymers and fuel cells produced therewith POWERZYME, INC. 2003-03-13 US disclosed
US-20030042462-A1 Magnetic fluids RIFFLE JUDY S (US) 2003-03-06 US disclosed
US-20030031911-A1 Biocompatible membranes and fuel cells produced therewith POWERZYME, INC. 2003-02-13 US disclosed
US-6464968-B2 BLOCK COPOLYMER STABILIZER, MAGNETIC PARTICLES AND A FLUID POLYSILOXANE MEDIUM, THE STABILIZER CONTAINS A BLOCK CAPABLE OF CHELATING THE METAL PARTICLES, AND END BLOCK IS COMPATIBLE WITH THE POLYSILOXANE MEDIUM; TREATING RETINAL DETACHMENT VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2002-10-15 US disclosed
US-20020141942-A1 MAGNETIC FLUIDS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 2002-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200399210-A1 PROCESS FOR PRODUCING SULFONIC ACID GROUP-CONTAINING MONOMER FOS, CLCN2, CLIC1 ESR1 1370/4885ESR2 2756/4885CA4 107/4885
US-20020141942-A1 MAGNETIC FLUIDS NEFM, STAMBP, CHMP4B ESR1 1763/4885ESR2 2928/4885CA4 1563/4885
US-11820733-B2 Process for producing sulfonic acid group-containing monomer FOS, CLCN2, CLIC1 ESR1 1370/4885ESR2 2756/4885CA4 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.